ABIVAX (EPA:ABVX) | WebDisclosure

Basculer en Français

10065	Companies
205754	Keywords
136002	Articles
109088	Press releases

Home
Companies
ABIVAX

PRESS RELEASE

published on 10/03/2024 at 08:30, 1 year 5 months ago

Abivax Reports Positive Interim Efficacy and Safety Analysis of Once-Daily 25mg Obefazimod in Moderate to Severe Ulcerative Colitis Patients After 2-Years of Open-Label Maintenance
Abivax announces positive interim results of obefazimod in ulcerative colitis patients after 2 years, showing maintenance of remission and safety profile consistency

Abivax Obefazimod Ulcerative Colitis Safety Efficacy
PRESS RELEASE

published on 10/03/2024 at 08:30, 1 year 5 months ago

Résultats positifs d'une analyse intermédiaire portant sur l'efficacité et la tolérance d’obefazimod 25 mg chez des patients atteints de RCH modérée à sévère après deux ans de maintenance en ouvert
Abivax annonce des résultats positifs d'une analyse intermédiaire sur l'efficacité d'obefazimod 25 mg pour les patients atteints de RCH modérée à sévère après 2 ans de traitement

Abivax Obefazimod Efficacité Tolérance RCH Modérée
BRIEF

published on 09/26/2024 at 08:35, 1 year 5 months ago

Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024

Abivax Obefazimod Ulcerative Colitis Phase 2b Study UEG Week 2024
BRIEF

published on 09/26/2024 at 08:35, 1 year 5 months ago

Abivax présentera trois résumés sur l'obéfazimod dans la rectocolite hémorragique lors de la semaine UEG 2024

Abivax Obefazimod Rectocolite Hémorragique Étude De Phase 2b Semaine UEG 2024
PRESS RELEASE

published on 09/26/2024 at 08:30, 1 year 5 months ago

Abivax annonce la présentation de trois abstracts sur Obefazimod dans la rectocolite hémorragique lors du congrès UEG Week 2024
Abivax annonce la présentation de trois abstracts sur Obefazimod dans la rectocolite hémorragique lors du congrès UEG Week 2024. Les présentations mettent en lumière l'efficacité et la sécurité du traitement

Abivax Obefazimod Phase 2b Rectocolite Hémorragique UEG Week
PRESS RELEASE

published on 09/26/2024 at 08:30, 1 year 5 months ago

Abivax to Present Three Abstracts for Obefazimod in Ulcerative Colitis at the UEG Week 2024
Abivax to present Phase 2b trial results of obefazimod in ulcerative colitis at UEG Week 2024, showcasing efficacy and safety data for potential oral therapy

Abivax Obefazimod Ulcerative Colitis Clinical Trial UEG Week 2024
PRESS RELEASE

published on 09/26/2024 at 08:30, 1 year 5 months ago

Abivax annonce la présentation de trois abstracts sur Obefazimod dans la rectocolite hémorragique lors du congrès UEG Week 2024
Abivax annonce la présentation de trois abstracts sur Obefazimod dans la rectocolite hémorragique lors du congrès UEG Week 2024

Abivax Obefazimod Rectocolite Hémorragique Traitement UEG Week 2024
BRIEF

published on 09/25/2024 at 22:06, 1 year 5 months ago

Abivax Announces Ulcerative Colitis Combination Therapy Strategy and Preclinical Data

Obefazimod Ulcerative Colitis Preclinical Data Combination Therapy Etrasimod
BRIEF

published on 09/25/2024 at 22:06, 1 year 5 months ago

Abivax annonce sa stratégie de traitement combiné contre la rectocolite hémorragique et ses données précliniques

Obefazimod Rectocolite Hémorragique Données Précliniques Etrasimod Thérapie Combinée
PRESS RELEASE

published on 09/25/2024 at 22:01, 1 year 5 months ago

Abivax Provides Update on Ulcerative Colitis Combination Therapy Program Strategy and Announces Early Preclinical Combination Data of Obefazimod and Etrasimod in Inflammatory Bowel Disease Mouse Model
Abivax announces preclinical data of Obefazimod and Etrasimod combination therapy in IBD mouse model, aiming to break through efficacy ceiling in UC treatment. More updates expected in Q4 2024

Abivax Obefazimod Preclinical Data Etrasimod IBD Mouse Model

Accesswire

Published on 03/23/2026 at 14:05, 11 minutes ago

Wellgistics Health Inc. Signs $105,000,000 Letter of Intent to Evaluate Potential Acquisition of Neuritek Therapeutics, Inc. which is Pioneering Innovative Therapies for Neurological and Psychiatric Disorders
Published on 03/23/2026 at 14:00, 16 minutes ago

BlackBerry AtHoc Advances Command Center for Faster Response and Tighter Control During Critical Operations
Published on 03/23/2026 at 13:05, 1 hour 11 minutes ago

SouthGobi Announces Disclosable and Connected Transaction Deferral of Payment Obligations Under Convertible Debenture and Amended and Restated Cooperation Agreement
Published on 03/23/2026 at 12:32, 1 hour 44 minutes ago

Sinopec Announced 2025 Annual Results Annual Payout Ratio Reached 81%
Published on 03/23/2026 at 12:30, 1 hour 46 minutes ago

Digi Power X to Announce 2025 Year End Financial Results on March 31st

View all ACCESSWIRE

EQS Group

Published on 03/23/2026 at 14:08, 8 minutes ago

Form 8.3 - The Vanguard Group, Inc.: International Personal Finance plc
Published on 03/23/2026 at 14:06, 10 minutes ago

Form 8.3 - The Vanguard Group, Inc.: British Land Company plc, The
Published on 03/23/2026 at 14:05, 11 minutes ago

Govee Introduces Outdoor Chromatic String Lights Featuring the Industry's First Single-Bulb Customization Technology
Published on 03/23/2026 at 14:04, 12 minutes ago

Form 8.3 - The Vanguard Group, Inc.: Beazley plc
Published on 03/23/2026 at 13:35, 41 minutes ago

Bitmine Immersion Technologies (BMNR) Announces ETH Holdings Reach 4.661 Million Tokens, and Total Crypto and Total Cash Holdings of $11.0 Billion

Les Echos

Published on 03/23/2026 at 08:10, 6 hours 6 minutes ago

Entrée en négociations exclusives de cession de la participation dans Winncare
Published on 03/20/2026 at 19:00, 2 days 19 hours ago

AXA - Conditions for availability or consultation of information relating to AXA’s Shareholders’ Meeting of April 30, 2026
Published on 03/20/2026 at 19:00, 2 days 19 hours ago

AXA - Modalités de mise à disposition ou de consultation des informations relatives à l’Assemblée Générale du 30 avril 2026
Published on 03/20/2026 at 18:15, 2 days 20 hours ago

Publication of AXA’s 2025 Universal Registration Document
Published on 03/20/2026 at 18:15, 2 days 20 hours ago

Mise à disposition du Document d’Enregistrement Universel 2025 d’AXA

View all LES ECHOS COMFI WIRE